Demand And Supply Side Regulation Of Biosimilar Markets In Germany, France And England And Its Implications For Market Access Of Biosimilars
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1562
https://www.valueinhealthjournal.com/article/S1098-3015(17)31896-X/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
1398
First Page :
A656
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31896-X&doi=10.1016/j.jval.2017.08.1562